1. Home
  2. Live Updates
  3. Insulet corp

Live Breaking News & Updates on Insulet corp

Stay informed with the latest breaking news from Insulet corp on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Insulet corp and stay connected to the pulse of your community

GLP-1 not all loss, sweet side emerges for med tech

Investors bailed on many med-tech companies last year, fearing that the frenzy surrounding GLP-1 agonists would tank companies in the weight-loss, diabetes and orthopedics segments. Their concerns now appear overblown in many instances, with some of the most directly affected businesses reporting a “rising tide” associated with an increased focus on obesity treatment that has lifted their boats rather than sinking them.

Bioworld-medtech , Zimmer-biomet-holdings-inc- , Stryker-corp- , Abbott-laboratories-inc- , Dexcom-inc- , Reshape-lifesciences-inc- , Insulet-corp- , Tandem-diabetes-care-inc- , Allurion-technologies-inc- , Glp-1 , Endocrine-metabolic

Medtronic scraps plans to buy wearable insulin patch maker Eoflow

One of the largest med-tech deals of 2023 was wiped off the charts when Medtronic plc terminated a $738 million agreement to acquire South Korean wearable insulin patch maker Eoflow Co. Ltd., citing “multiple breaches” under its agreements, on Dec. 6.

South-korea , South-korean , Medtronic , Eoflow-co , Medtronic-plc , Eoflow-co-ltd- , Eopatch , Insulet-corp- , Omnipod , Termination , Insulin

Diabetes stocks are surprise winners from Novo Nordisk's Wegovy study, analysts say

Eli Lilly also scores, analysts say, as trial results leave door open for Zepbound to top Wegovy’s benefits

Denmark , Danish , Eli-lilly , Novo-nordisk , Raymond-james , Drug-administration , Intuitive-surgical-inc , Dexcom-inc , Davita-inc , Insulet-corp , Leerink-partners , Intuitive-surgical

S&P 500 Futures Decline in Premarket Trading; BILL Holdings, Fortinet Lag

With U.S. stock markets set to open in two hours, (SQ) was up 17.0% in pre-market trading, and (EXPE) was up 10.7%. (PODD), (DKNG), and (MGA) were all...

Draftkings-inc , Insulet-corp , Magna-international-inc , Expedia-group-inc , Fortinet-inc , Block-inc , Holdings-inc , Expedia-group , Magna-international , Article-normal , Computers-consumer-electronics

Insulet shares rebound after results top estimates

Insulin pump maker seeks to dispel investor fears that Ozempic and Wegovy could shrink the market for its products

James-hollingshead , Insulet-corp , Novo-nordisk , Article-normal , Pharmaceuticals , Medical-equipment-supplies , Port-harbor-operations , Healthcare-life-sciences , Specialized-drugs-medications , Hormone-products , Diabetes-drugs , Water-transport-shipping

Diabetes stocks jump as analysts see obesity-drug recovery ahead of schedule

DexCom's strong quarterly results give device makers a boost.

Kevin-sayer , Insulet-corp , Tandem-diabetes-care-inc , Dexcom-inc , Tandem-diabetes-care , Novo-nordisk , Article-normal , Pharmaceuticals , Medical-equipment-supplies , Port-harbor-operations , Healthcare-life-sciences

These diabetes stocks, pummeled by the Ozempic craze, now look like bargains, analysts say

DexCom could be the first stock to break out of ‘GLP jail,’ analysts say, as market continues to punish device makers

Hamburg , Germany , Raymond-james , Dexcom-inc , Tandem-diabetes-care-inc , European-association-for-the-study-of-diabetes , Systems-inc , Insulet-corp , Novo-nordisk , Eli-lilly , Inspire-medical-systems , Freestyle-libre

Insulet shares rise as analysts say weight-loss drug fears may be overblown

Insulet Corp. shares gained 4% premarket on Monday after Jefferies analysts upgraded the stock to buy from hold, saying its valuation looks attractive after...

Hamburg , Germany , Insulet-corp , European-association-for-the-study-of-diabetes , European-association , Article-normal , Health-care , Insulet-corp- , Podd ,

Wall Street analysts expect the S&P 500 to rise 19% over the next 12 months. Here are their 10 favorite stocks.

Outside of a handful of highflying technology stocks, U.S. stocks have been practically flat in 2023, but on Wall Street, some analysts remain as bullish as...

Wall-street , Article-normal , Textiles , Fiber-yarn-thread , Airlines , Passenger-airlines , Port-harbor-operations , Computer-services , Audiovisual-production , Television-program-production , Air-transport

These 20 growth stocks are worth considering on a pullback, says Citi

The Russell 1000 Growth Index is down modestly from recent highs, but Citi says there is “more carnage under the surface.”

Scott-chronert , Article-normal , Machinery , Computers-consumer-electronics , Computer-storage-devices , Retail-wholesale , Household-goods-retailing , Decorating-diy-hardware-retailing , Specialty-retailing , Port-harbor-operations , Insurance